|Table of Contents|

Progresses on the correlation between intestinal microbiota and breast cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2021 03
Page:
539-542
Research Field:
Publishing date:

Info

Title:
Progresses on the correlation between intestinal microbiota and breast cancer
Author(s):
DONG AruhanZHANG Ying
The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300193,China.
Keywords:
breast cancerintestinal microbiotapathogenic mechanisms
PACS:
R737.9
DOI:
DOI:10.3969/j.issn.1672-4992.2021.03.041
Abstract:
In the latest global cancer statistics,the incidence of breast cancer is increasing year by year,and is ranking first in the incidence of breast cancer.The prevention and treatment has become important.Occurrence of breast cancer is affected by many factors.In recent years,with the completion of the human genome project,gut microbiota-related genes have been found to be involved in the development of various diseases,and participate in many pathological processes of breast cancer by affecting estrogen levels,immune function,and the microbiota of local tissue of the breast.In recent years,domestic and foreign literatures have explored the correlation and mechanism between intestinal flora and breast cancer,and have in-depth understanding of the relationship between the them.However,due to the many influencing factors of breast cancer,large-scale experiments are still needed to observe and verify to develop a new breast cancer prevention strategy.

References:

[1]BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:A Cancer Journal for Clinicians,2018,68(6):394-424.
[2]SCOTT AJ,ALEXANDER JL,MERRIFIELD CA,et al.International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis[J].Gut,2019,68(9):1624-1632.
[3]QIN J,LI R,RAES J,et al.A human gut microbial gene catalogue established by metagenomic sequencing[J].Nature,2010,464(7285):59.
[4]BARD JM,LUU HT,DRAVET F,et al.Relationship between intestinal microbiota and clinical characteristics of patients with early stage breast cancer[J].FASEB J,2015,29:914.
[5]LUU T,MICHEL C,BARD J,et al.Intestinal proportion of blautia sp. Is associated with clinical stage and histoprognostic grade in patients with early-stage breast cancer[J].Nutr Cancer,2017,69(2):267-275.
[6]PLAZA-DIAZ J,ALVAREZ-MERCADO AI,RUIZ-MARIN CM,et al.Association of breast and gut microbiota dysbiosis and the risk of breast cancer:A case-control clinical study[J].BMC Cancer,2019,19(1):495.
[7]SU J,LI D,CHEN Q,et al.Anti-breast cancer enhancement of a polysaccharide from spore of ganoderma lucidum with paclitaxel:Suppression on tumor metabolism with gut microbiota reshaping[J].Front Microbiol,2018,9:3099.
[8]ERDMAN SE,POUTAHIDIS T.Gut bacteria and cancer[J].Biochim Biophys Acta,2015,1856(1):86-90.
[9]PAULSEN JA,PTACEK TS,CARTER SJ,et al.Gut microbiota composition associated with alterations in cardiorespiratory fitness and psychosocial outcomes among breast cancer survivors[J].Support Care Cancer,2017,25(5):1563-1570.
[10]OKUBO R,KINOSHITA T,KATSUMATA N,et al.Impact of chemotherapy on the association between fear of cancer recurrence and the gut microbiota in breast cancer survivors[J].Brain Behav Immun,2019,85:186-191.
[11]BROWN SB,HANKINSON SE.Endogenous estrogens and the risk of breast,endometrial,and ovarian cancers[J].Steroids,2015,99:8-10.
[12]SAMPSON JN,FALK RT,SCHAIRER C,et al.Association of estrogen metabolism with breast cancer risk in different cohorts of postmenopausal women[J].Cancer Res,2017,77:918-925.
[13]FUHRMAN BJ,FEIGELSON HS,FLORES R,et al.Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women[J].J Clin Endocrinol Metab,2014,99(12):4632-4640.
[14]DABEK M,MCCRAE SI,STEVNES VJ,et al.Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria[J].FEMS Microbiol Ecol,2008,66(3):487-495.
[15]PLOTTEL CS,BLASER MJ.Microbiome and malignancy[J].Cell Host Microbe,2011,10(4):324-335.
[16]GOEDERT JJ,JONES G,HUA X,et al.Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women:A population-based case-control pilot study[J].J Natl Cancer Inst,2015,107(8):147.
[17]SHI J,GENG C,SANG M,et al.Effect of gastrointestinal microbiome and its diversity on the expression of tumor-infiltrating lymphocytes in breast cancer[J].Oncol Lett,2019,17(6):5050-5056.
[18]GELLER LT,BARZILY-ROKNI M,DANINO T,et al.Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine[J].Science,2017,357(6356):1156-1160.
[19]FESSLER J,V MATSON TF.Gajewski,exploring the emerging role of the microbiome in cancer immunotherapy[J].J Immunother Cancer,2019,7(1):108.
[20]FERNANDEZ MF,REINA-PEREZ I,ASTORGA JM,et al.Breast cancer and its relationship with the microbiota[J].Int J Environ Res Public Health,2018,15(8):1747.
[21]GOEDERT JJ,HUA X,BIELECKA A,et al.Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota[J].Br J Cancer,2018,118(4):471-479.
[22]LAKRITZ JR,POUTAHIDIS T,LEVKOVICH T,et al.Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice[J].Int J Cancer,2014,135(3):529-540.
[23]LAKRITZ JR,POUTAHIDIS T,MIRABAL S,et al.Gut bacteria require neutrophils to promote mammary tumorigenesis[J].Oncotarget,2015,6(11):9387-9396.
[24]NUNEZ NP,PERKINS SN,SMITH NC,et al.Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones[J].Nutr Cancer,2008,60:534-541.
[25]LUU TH,BARD JM,CARBONNELLE D,et al.Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells[J].Cell Oncol(Dordr),2018,41(1):13-24.
[26]GOLDBERG AA,RICHARD VR,KYRYAKOV P,et al.Chemical genetic screen identifies lithocholic acid as an anti-aging compound that extends yeast chronological life span in a TOR-independent manner,by modulating housekeeping longevity assurance processes[J].Aging(Albany NY),2010,2(7):393-414.
[27]MENG S,CHEN B,YANG J,et al.Study of microbiomes in aseptically collected samples of human breast tissue using needle biopsy and the potential role of in situ tissue microbiomes for promoting malignancy[J].Front Oncol,2018,8:318.
[28]HIEKEN TJ,CHEN J,HOSKIN TL,et al.The microbiome of aseptically collected human breast tissue in benign and malignant disease[J].Sci Rep,2016,6:30751.
[29]BANERJEE S,WEI Z,TAN F,et al.Distinct microbiological signatures associated with triple negative breast cancer[J].Sci Rep,2015,5:15162.
[30]BANERJEE S,TIAN T,WEI Z,et al.Distinct microbial signatures associated with different breast cancer types[J].Front Microbiol,2018,9:951.
[31]MCNABNEY SM,HENAGAN TM.Short chain fatty acids in the colon and peripheral tissues:A focus on butyrate,colon cancer,obesity and insulin resistance[J].Nutrients,2017,9(12):1348.
[32]PAUL B,ROYSTON K J,LI Y,et al.Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition[J].PLoS One,2017,12(12):e0189756.
[33]ZHU J,LIAO M,YAO Z,et al.Breast cancer in postmenopausal women is associated with an altered gut metagenome[J].Microbiome,2018,6(1):136.
[34]ROGERS GB,KEATING DJ,YOUNG RL,et al.From gut dysbiosis to altered brain function and mental illness:Mechanisms and pathways[J].Mol Psychiatry,2016,21(6):738-748.
[35]VAN DE WOUW M,BOEHME M,LYTE JM,et al.Short-chain fatty acids:Microbial metabolites that alleviate stress-induced brain-gut axis alterations[J].J Physiol,2018,596(20):4923-4944.

Memo

Memo:
-
Last Update: 2021-01-02